Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth o
Go back to Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth o| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 72.78 +0.25 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.53 | 52 Week High | $39.41 | |||
| Open | $73.06 | 52 Week Low | $25.98 | |||
| Day High | $73.80 | P/E | 102.51 | |||
| Day Low | $72.76 | EPS | $0.71 | |||
| Volume | 625,055 | |||||
